257 related articles for article (PubMed ID: 29071155)
1. Risk factors and prognosis of intravesical recurrence after surgical management of upper tract urothelial carcinoma: A 30-year single centre experience.
Elawdy MM; Osman Y; Taha DE; Zahran MH; El-Halwagy S; Garba ME; Harraz AM
Arab J Urol; 2017 Sep; 15(3):216-222. PubMed ID: 29071155
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of subsequent non-muscle-invasive bladder cancer treated with intravesical Bacillus Calmette-Guérin after radical nephroureterectomy for upper urinary tract urothelial carcinoma.
Miyake M; Tatsumi Y; Matsumoto H; Nagao K; Matsuyama H; Inamoto T; Azuma H; Yasumoto H; Shiina H; Fujimoto K;
BJU Int; 2018 May; 121(5):764-773. PubMed ID: 29281857
[TBL] [Abstract][Full Text] [Related]
3. Predictors of Intravesical Recurrence After Radical Nephroureterectomy and Prognosis in Patients with Upper Tract Urothelial Carcinoma.
Li YR; Yu KJ; Chang YH; Lin PH; Shao IH; Kan HC; Chu YC; Chuang CK; Pang ST; Liu CY
Cancer Manag Res; 2020; 12():7439-7450. PubMed ID: 32884355
[TBL] [Abstract][Full Text] [Related]
4. Muscle-invasive bladder and urethral cancer recurrence after surgical management of upper tract urothelial carcinoma: A review of 305 patients.
Elawdy MM; Osman Y; Taha DE; El-Halwagy S
Turk J Urol; 2018 May; 44(3):213-220. PubMed ID: 29733795
[TBL] [Abstract][Full Text] [Related]
5. Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma.
Xylinas E; Rink M; Cha EK; Clozel T; Lee RK; Fajkovic H; Comploj E; Novara G; Margulis V; Raman JD; Lotan Y; Kassouf W; Fritsche HM; Weizer A; Martinez-Salamanca JI; Matsumoto K; Zigeuner R; Pycha A; Scherr DS; Seitz C; Walton T; Trinh QD; Karakiewicz PI; Matin S; Montorsi F; Zerbib M; Shariat SF;
Eur Urol; 2014 Jan; 65(1):210-7. PubMed ID: 22579047
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
[TBL] [Abstract][Full Text] [Related]
7. Independent predictors for bladder outcomes after treatment of intravesical recurrence following radical nephroureterectomy in patients with primary upper tract urothelial carcinoma.
Tanaka N; Kikuchi E; Kanao K; Matsumoto K; Shirotake S; Kobayashi H; Miyazaki Y; Ide H; Obata J; Hoshino K; Hayakawa N; Hagiwara M; Kosaka T; Oyama M; Miyajima A; Momma T; Nakagawa K; Jinzaki M; Hasegawa S; Nakajima Y; Oya M
Ann Surg Oncol; 2014 Sep; 21(9):3151-8. PubMed ID: 24682698
[TBL] [Abstract][Full Text] [Related]
8. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update.
Rouprêt M; Babjuk M; Compérat E; Zigeuner R; Sylvester RJ; Burger M; Cowan NC; Gontero P; Van Rhijn BWG; Mostafid AH; Palou J; Shariat SF
Eur Urol; 2018 Jan; 73(1):111-122. PubMed ID: 28867446
[TBL] [Abstract][Full Text] [Related]
9. Clinical implications of intravesical recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma.
Yamashita S; Ito A; Mitsuzuka K; Tochigi T; Namima T; Soma F; Aizawa M; Ioritani N; Kaiho Y; Arai Y
Int J Urol; 2016 May; 23(5):378-84. PubMed ID: 26780531
[TBL] [Abstract][Full Text] [Related]
10. Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience.
Cutress ML; Stewart GD; Wells-Cole S; Phipps S; Thomas BG; Tolley DA
BJU Int; 2012 Dec; 110(11):1608-17. PubMed ID: 22564677
[TBL] [Abstract][Full Text] [Related]
11. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update.
Rouprêt M; Babjuk M; Compérat E; Zigeuner R; Sylvester RJ; Burger M; Cowan NC; Böhle A; Van Rhijn BW; Kaasinen E; Palou J; Shariat SF
Eur Urol; 2015 Nov; 68(5):868-79. PubMed ID: 26188393
[TBL] [Abstract][Full Text] [Related]
12. Bladder Recurrence Following Upper Tract Surgery for Urothelial Carcinoma: A Contemporary Review of Risk Factors and Management Strategies.
Mertens LS; Sharma V; Matin SF; Boorjian SA; Houston Thompson R; van Rhijn BWG; Masson-Lecomte A
Eur Urol Open Sci; 2023 Mar; 49():60-66. PubMed ID: 36793750
[TBL] [Abstract][Full Text] [Related]
13. The diagnostic ureteroscopy before radical nephroureterectomy in upper urinary tract urothelial carcinoma is not associated with higher intravesical recurrence.
Lee HY; Yeh HC; Wu WJ; He JS; Huang CN; Ke HL; Li WM; Li CF; Li CC
World J Surg Oncol; 2018 Jul; 16(1):135. PubMed ID: 29986730
[TBL] [Abstract][Full Text] [Related]
14. Risk stratification for bladder recurrence of upper urinary tract urothelial carcinoma after radical nephroureterectomy.
Ishioka J; Saito K; Kijima T; Nakanishi Y; Yoshida S; Yokoyama M; Matsuoka Y; Numao N; Koga F; Masuda H; Fujii Y; Sakai Y; Arisawa C; Okuno T; Nagahama K; Kamata S; Sakura M; Yonese J; Morimoto S; Noro A; Tsujii T; Kitahara S; Gotoh S; Higashi Y; Kihara K
BJU Int; 2015 May; 115(5):705-12. PubMed ID: 24612074
[TBL] [Abstract][Full Text] [Related]
15. Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of localized high-risk disease.
Gakis G; Schubert T; Alemozaffar M; Bellmunt J; Bochner BH; Boorjian SA; Daneshmand S; Huang WC; Kondo T; Konety BR; Laguna MP; Matin SF; Siefker-Radtke AO; Shariat SF; Stenzl A
World J Urol; 2017 Mar; 35(3):327-335. PubMed ID: 27043218
[TBL] [Abstract][Full Text] [Related]
16. Risk factors and oncological outcome for intravesical recurrence in organ-confined upper urinary tract urothelial carcinoma patients after radical nephroureterectomy: A propensity score-matched case control study.
Jiang Y; Yao Z; Zhu X; Wu B; Bai S
Int J Surg; 2020 Apr; 76():28-34. PubMed ID: 32081714
[TBL] [Abstract][Full Text] [Related]
17. Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review.
Cutress ML; Stewart GD; Zakikhani P; Phipps S; Thomas BG; Tolley DA
BJU Int; 2012 Sep; 110(5):614-28. PubMed ID: 22471401
[TBL] [Abstract][Full Text] [Related]
18. Bacillus Calmette-Guérin failure in patients with non-muscle-invasive urothelial carcinoma of the bladder may be due to the urologist's failure to detect urothelial carcinoma of the upper urinary tract and urethra.
Giannarini G; Birkhäuser FD; Recker F; Thalmann GN; Studer UE
Eur Urol; 2014 Apr; 65(4):825-31. PubMed ID: 24144432
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic factors for intravesical recurrence after surgery for upper tract urothelial carcinoma in renal transplant recipients].
Liu YQ; Lu J; Zhao L; Hou XF; Ma LL
Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Aug; 47(4):605-10. PubMed ID: 26284394
[TBL] [Abstract][Full Text] [Related]
20. Bladder mapping of tumour recurrence after radical nephroureterectomy for upper tract urothelial carcinoma and its influence on oncological outcomes.
Belhadj Y; Grande P; Seisen T; Gobert A; Gomez FD; Cussenot O; Roupret M
BJU Int; 2019 Apr; 123(4):618-623. PubMed ID: 30548115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
